Research progress of radiomics in the treatment of ovarian cancer
Ovarian cancer,a prevalent malignant gynecological tumor,is often associated with dismal prognosis and high recurrence rates. This is primarily attributed to its late-stage diagnosis,frequent peritoneal metastasis,and the development of resistance to platinum-based chemotherapy,a first-line treatment. In treating ovarian cancer,utmost consideration must be given to the prognosis and quality of life of patients. Timely diagnosis and the selection of appropriate chemotherapy drugs are pivotal in extending progression-free survival (PFS) and enhancing the patient's overall well-being. This review endeavors to encapsulate the advancements in radiomics research pertaining to ovarian cancer's preoperative prediction,assessment of chemotherapy response,platinum chemoresistance,and prognosis prediction. Its objective is to empower clinicians with the knowledge to leverage radiomics technology in more precisely forecasting disease progression and treatment outcomes,ultimately leading to the formulation of personalized treatment plans that optimize patient quality of life. Future research aims to delve deeper into the fusion of multi-omics data,combining radiomics with genomics and proteomics,and this review hopes to serve as a valuable resource and inspiration for researchers in their endeavors.
国家科技期刊平台
NSTL
万方数据
